Thank you for Subscribing to Med Tech Business Review Weekly Brief
Kevin Badin, Founder and Director Caution in medical-device compliance can quietly harden into bureaucracy. Another procedure is added. Responsibilities are restated, explanations accumulate and documents are reviewed simply because the system has always operated that way. Eventually, the quality system meant to support the business becomes a second operation that the business must support.
ORA innovations starts from the opposite premise.
“The quality management system must serve the company, not otherwise,” says Kevin Badin, founder and director.
ORA innovations takes a different view of what good regulatory work should accomplish. The goal is not to produce the most documentation, but to understand the device, its risk classification and what its intended market demands. Kevin has seen companies maintain 45 to 50 standard operating procedures. By comparison, he says ORA has generally not needed more than roughly 18 to 20 SOPs in the quality systems it has helped implement.
The smaller number does not mean lighter compliance. It reflects sharper judgment about what is required, what is useful and what merely consumes attention. ORA innovations helps clients distinguish legal obligations from the standards that support them, identify the provisions that genuinely apply and translate those requirements into processes employees can follow in daily work.
More than 30 years of experience spanning manufacturing, quality and regulatory affairs, including 23 years under ORA innovations, gives the consultancy the perspective to make those distinctions.
ORA team puts that experience into practice by mapping the path from proof of concept through design, prototyping, manufacturing, market entry and post-market obligations. A startup may need help establishing an ISO 13485-aligned quality management system and navigating its first regulatory clearance. An established manufacturer may need auditing, training, documentation review or improvements to an existing framework. ORA has worked with organizations ranging from two- to five-person teams to companies with 2,000 to 3,000 employees.
Bring Regulation into Development Earlier
Kevin encourages development teams to understand the essential requirements for a device before significant resources go into design and prototyping. Regulatory requirements identified early can inform development team while decisions are still practical to change, reducing the risk of costly rework after a technically viable product has already been developed.
-
The quality measurement system must serve the company, not otherwise.
His PDMAC model—Plan, Do, Measure, Analyze and Correct—extends the same thinking into continuous improvement. ORA’s team monitors regulatory updates, alerts and device-related developments, passing relevant information to clients that may be affected. A device problem identified in one market can have implications for similar products elsewhere.
Training and continuous education help clients translate those developments into their processes, documentation and day-to-day decisions.
Simplify Without Diluting Control
In two client engagements, ORA’s team found procedures filled with repeated definitions, responsibilities and explanations. Instead of showing employees how to perform the work, documents carried material that could be consolidated elsewhere.
ORA team recommended removing repetition and keeping procedures focused on execution. Badin applies similar reasoning to routine document reviews. He challenges the automatic review and restamping of documents every year when no regulatory requirement, audit finding or process change calls for revision. The objective is not to control less. It is to meet applicable requirements without consuming time and resources on documentation that adds little to the process.
Handing Over the Torch
ORA innovations describes the client relationship through the image of carrying a torch together. The consultancy helps illuminate the path through quality-system implementation and regulatory preparation. Once clients can move forward independently, ORA hands over the torch while remaining available for training and ongoing support, which is why MedTech Business Review APAC recognizes it as Top Medical Devices Consultancy Services for Quality & Regulatory Affairs in APAC 2026.
Building Regulatory Clarity into Medical Device Development
A medical device can be technically ready yet still be stalled because the path to clearance depends on where it will be sold and how it is classified. Australia, the US, Europe and Canada do not impose identical routes, and requirements shift across other markets. For executives choosing quality and regulatory consulting, the real question is not whether a consultancy knows the rules. It is whether it can translate applicable requirements into a practical route without importing unnecessary obligations from another jurisdiction or risk class.
Classification is where that judgment starts. A low-risk device and an implantable device can face different evidence and conformity requirements, while market entry may involve a CE mark or FDA clearance, with other national processes depending on location. A useful consultancy should connect device class to the legal requirements that apply, and then distinguish those obligations from voluntary standards that support compliance. That separation can prevent design teams from discovering late that a product was developed without enough attention to its intended market before design choices become expensive to revisit later.
The quality management system is another point where poor advice can create work rather than control it. ISO 13485 may sit at the center of a medical device quality system, but documentation should fit the company's processes and stage of development. Excessive standard operating procedures, repeated definitions, duplicated responsibility statements and routine review stamps can turn document maintenance into its own workload. Buyers should look for advisors who simplify the system without weakening required controls and can explain why a document exists before adding it.
“ORA innovations begins by mapping company processes so documentation reflects how the device is developed and controlled rather than expanding into unnecessary procedure volume.”
Company maturity changes the assignment. An established manufacturer may already have a certified system and need targeted auditing, training, document review or quality-system improvement. A startup may require more help understanding the route from proof of concept through design development, prototyping and eventual market entry. Consulting depth should flex around existing systems, internal expertise, device class and the work still needed for clearance. A fixed package is less useful than support that starts by mapping how the business develops and controls the device.
Regulatory support also loses value if it stops once the initial system is built. Authorities update requirements, issue alerts, publish information on device problems and maintain complaint databases that can affect related products elsewhere. Medical device teams need a way to keep relevant changes connected to design decisions and quality documents rather than treating regulatory review as periodic paperwork. Training matters because internal teams eventually carry the system forward and need to recognize which changes warrant action.
ORA innovations fits this buying logic through a consulting model centered on quality management systems and regulatory affairs. It supports medical device companies with ISO 13485 implementation, audits, training and documentation review, while also helping them interpret market-specific requirements for CE marking, FDA clearance, TGA registration and other country-specific submissions. ORA innovations begins by mapping company processes so documentation reflects how the device is developed and controlled rather than expanding into unnecessary procedure volume. It also adjusts involvement to the client's size and existing quality maturity. For executives that need regulatory guidance tied closely to process design and practical documentation, ORA innovations merits serious consideration for medical device quality and regulatory consulting.
...Read more
Medical Device Quality and Regulatory Affairs Consultancy Services in APAC Info
Q1
What Do Medical Device Quality and Regulatory Consultants Help Companies Manage?
Medical Devices Consultancy Services for Quality & Regulatory Affairs in APAC help companies interpret regulatory requirements and build quality processes that fit their devices, markets and development stages. Support can extend from proof of concept and design through prototyping, manufacturing, market entry and post-market obligations. Consultants may also assist with quality management systems, audits, training and documentation. The aim is to translate complex requirements into practical processes that support compliance without creating unnecessary administrative work for development and operational teams.
Q2
How Does ORA Innovations Approach Medical Device Quality and Regulatory Compliance?
ORA innovations provides Medical Devices Consultancy Services for Quality & Regulatory Affairs in APAC with an emphasis on making compliance workable within everyday operations. It first considers the device, its risk classification and the requirements of its intended market. The consultancy helps implement ISO 13485-aligned quality management systems while distinguishing applicable legal obligations from supporting standards. Its experience spans more than 30 years across manufacturing, quality and regulatory affairs, including 23 years operating as ORA innovations.
Q3
Why Should Regulatory Requirements Be Considered Early in Medical Device Development?
A technically successful device may still face regulatory obstacles if applicable requirements are addressed too late. Medical Devices Consultancy Services for Quality & Regulatory Affairs in APAC can help development teams identify essential requirements before substantial resources are committed to design and prototyping. Device classification, intended market and regulatory pathway can influence evidence, documentation and development decisions. Addressing these factors earlier gives teams an opportunity to incorporate regulatory needs while design choices remain practical to change, rather than revisiting them later.
Q4
What Should Companies Consider When Choosing a Medical Device Regulatory Consultant?
Companies should assess whether a consultant can translate regulatory obligations into processes suited to their device and organization. Medical Devices Consultancy Services for Quality & Regulatory Affairs in APAC may need to account for differences in device classification, company maturity and intended markets. Experience with quality management systems, documentation, audits and market-specific pathways is also relevant. A consultant should be able to explain which requirements apply and why, helping companies avoid adding procedures or controls that do not contribute to compliance or effective operations.
Q5
How Does ORA Innovations Simplify Quality Systems Without Weakening Control?
ORA innovations approaches Medical Devices Consultancy Services for Quality & Regulatory Affairs in APAC by focusing documentation on what employees actually need to perform their work. In some engagements, it has recommended removing repeated definitions, responsibilities and explanations from procedures and consolidating that information elsewhere. ORA innovations has generally implemented quality systems with roughly 18 to 20 standard operating procedures, compared with systems Kevin Badin has encountered containing 45 to 50. The objective is fewer unnecessary administrative steps, not fewer applicable controls.
Q6
How Can Regulatory Consulting Support Medical Devices After Market Entry?
Regulatory responsibilities continue after a device reaches the market. Medical Devices Consultancy Services for Quality & Regulatory Affairs in APAC can help organizations monitor regulatory updates, safety information and device-related developments that may affect existing products or quality processes. Relevant changes may require updates to documentation, training or internal procedures. Ongoing education also helps internal teams understand when action is necessary. This makes post-market regulatory support part of maintaining an effective quality system rather than treating compliance as complete once initial market authorization is achieved.
